Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Nurix Therapeutics, Inc. (NRIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/12/2023 |
10-Q
| Quarterly Report for the period ended August 31, 2023 |
| 07/13/2023 |
10-Q
| Quarterly Report for the period ended May 31, 2023 |
| 04/13/2023 |
10-Q
| Quarterly Report for the period ended February 28, 2023 |
| 10/06/2022 |
10-Q
| Quarterly Report for the period ended August 31, 2022 |
| 07/07/2022 |
10-Q
| Quarterly Report for the period ended May 31, 2022 |
| 04/08/2022 |
10-Q
| Quarterly Report for the period ended February 28, 2022 |
| 10/14/2021 |
10-Q
| Quarterly Report for the period ended August 31, 2021 |
| 07/13/2021 |
10-Q
| Quarterly Report for the period ended May 31, 2021 |
| 04/13/2021 |
10-Q
| Quarterly Report for the period ended February 28, 2021 |
| 10/14/2020 |
10-Q
| Quarterly Report for the period ended August 31, 2020 |
|
|